DNA methylation and ischemic stroke

Takeaway

  • CASZ1 is hypomethylated in Chinese patients with hypertensive ischemic stroke (IS), suggesting that DNA methylations may be a risk factor for hypertension and ischemic stroke.

Why this matters

  • Genetic and epigenetic factors are widely implicated in IS and hypertension, an important IS causative factor; however, while GWAS studies have identified several linked loci for blood pressure and IS, underlying functional factors are not fully understood.

  • Identification of high-risk genes and interactions for IS and hypertension has important implications for modifiable risk factor management such as diet, given that IS is the second leading cause of death worldwide.

続きを読む

ログインまたは新規会員登録するとneurodiemのすべてのコンテンツにアクセスできます。

会員登録がお済みの方はこちら ログイン

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.